Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Sell
1,016
-312
-23% -$97.2K ﹤0.01% 1153
2026
Q1
$388K Sell
1,328
-104
-7% -$33.4K ﹤0.01% 1055
2025
Q4
$408K Buy
+1,432
New +$407K ﹤0.01% 1015
2025
Q1
$449K Buy
1,333
+620
+87% +$225K ﹤0.01% 946
2024
Q4
$246K Buy
+713
New +$259K ﹤0.01% 1172
2020
Q4
Sell
-132
Closed -$14K 1742
2020
Q3
$14K Buy
+132
New +$15K ﹤0.01% 1745
2019
Q4
Sell
-2,345
Closed -$205K 3076
2019
Q3
$205K Buy
2,345
+50
+2% +$4.29K ﹤0.01% 1154
2019
Q2
$208K Buy
2,295
+1,140
+99% +$102K ﹤0.01% 1147
2019
Q1
$101K Buy
1,155
+650
+129% +$55.9K ﹤0.01% 1413
2018
Q4
$41K Buy
+505
New +$47.3K ﹤0.01% 1677
2016
Q4
Sell
-79
Closed -$4K 2541
2016
Q3
$4K Hold
79
﹤0.01% 2303
2016
Q2
$4K Buy
+79
New +$3.82K ﹤0.01% 2280
2016
Q1
Sell
-15
Closed 2677
2015
Q4
$0 Sell
15
-24,520
-100% -$1.01M ﹤0.01% 2712
2015
Q3
$956K Buy
24,535
+24,520
+163,467% +$1.08M 0.01% 741
2015
Q2
$0 Hold
15
﹤0.01% 2730
2015
Q1
$0 Buy
+15
New +$663 ﹤0.01% 2501
2014
Q4
Sell
-15
Closed 2568
2014
Q3
$0 Buy
+15
New +$589 ﹤0.01% 2485

Other funds holding KAI

Glenmede Trust's KAI Position: Q2 2026 in Review

Glenmede Trust reduced its Kadant (KAI) stake by 23% in Q2 2026, selling an estimated $97.2K and leaving 1,016 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Glenmede Trust first reported a position in KAI in Q3 2014 and has held it in 17 quarters since. The position peaked at $956K in Q3 2015. 326 funds tracked by Wall St. Rank hold KAI as of Q2 2026.

  • Glenmede Trust held 1,016 shares of Kadant worth $319K as of Q2 2026.
  • Glenmede Trust sold 312 Kadant shares in Q2 2026, an estimated $97.2K.
  • Kadant made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1153 holding.
  • Glenmede Trust first reported a position in Kadant in Q3 2014 and has held it in 17 quarters since.
  • Glenmede Trust's Kadant position peaked at $956K in Q3 2015.
  • 326 funds tracked by Wall St. Rank held Kadant as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.